What is Tolebrutinib? The world’s first oral treatment approved in UAE for progressive multiple sclerosis | World News
The Emirates Drug Establishment approved Tolebrutinib, making the UAE the first country to authorize this oral treatment for SPMS/ Representative image In a global first, the Emirates Drug Establishment (EDE) has approved Tolebrutinib, the only oral treatment specifically developed to slow disability progression in adults with non-relapsing secondary progressive multiple sclerosis (SPMS). The landmark decision […]